SOURCE: Hansen Medical, Inc.

Hansen Medical, Inc.

January 03, 2011 16:01 ET

Hansen Medical to Present at the 29th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, CA--(Marketwire - January 3, 2011) -  Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that President and CEO Bruce Barclay is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference. The conference is being held January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco, California. Hansen Medical is scheduled to present on Thursday, January 13, 2011 at 8:30 a.m. Pacific Time.

Hansen Medical will provide a live webcast of the audio presentation. Interested parties may access the live webcast by visiting the investor relations section of Hansen Medical's web site at www.hansenmedical.com. A replay of the webcast will be available at the site after the presentation.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Sensei® system and its Sensei X Robotic Catheter System were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei and Sensei X systems for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established during EP procedures, such as guiding catheters in the treatment of AF. In the European Union, the Sensei and the Sensei X systems are cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.

Contact Information

  • Investor Contacts:
    Peter Osborne
    Interim CFO
    Hansen Medical
    650.404.5800

    Matt Clawson
    Allen & Caron Inc.
    949.474.4300
    Email Contact